ABSTRACT
BACKGROUND: Receiving a diagnosis of multiple sclerosis (MS) can be stressful; later, patients may conceal their diagnosis. Here, we aimed to (1) assess prevalence of disclosure and concealment behaviors, and (2) explore whether diagnosis experience is associated with later concealment and if MS provider engagement on this topic modifies concealment. METHODS: In a survey-based study, MS patients completed DISCO-MS assessing disclosure and concealment and responded to questions about diagnosis experience and practitioner attention to disclosure. Frequency analysis and Pearson's correlations were used in exploratory analyses. RESULTS: 428 adults with MS participated. 49% (N = 201) conceal their diagnosis. Higher education [t(405) = 3.66, p < 0.001], younger age (r = -0.15, p = 0.002), and shorter disease duration (r = -0.18, p = 0.010) were associated with higher concealment. 39% (N = 159) anticipate negative consequences of disclosure. Individuals reporting positive diagnosis experience (26%, N = 102) were less likely to conceal later in disease course compared to those with negative experience (34%, N = 136) [t(233) = 2.483, p = 0.014]. Patients whose MS providers discussed disclosure (23%, N = 73) anticipated less negative consequences of disclosure [t(323) = 2.475, p = 0.014]. CONCLUSIONS: Diagnosis concealment is common in MS. Favorable diagnosis experience and provider attention to the topic of disclosure throughout the MS disease course may influence diagnosis concealment.
Subject(s)
Multiple Sclerosis , Adult , Humans , Multiple Sclerosis/diagnosis , Multiple Sclerosis/epidemiology , Surveys and QuestionnairesABSTRACT
BACKGROUND: Studies on the effectiveness of multimodal analgesia, particularly in patients at higher perioperative risk from obstructive sleep apnoea (OSA), are lacking. We aimed to assess the impact of multimodal analgesia on opioid use and complications in this high-risk cohort. METHODS: We conducted a population-based retrospective cohort study of OSA patients undergoing elective lower extremity joint arthroplasty (2006-16, Premier Healthcare database). Multimodal analgesia was defined as opioid use with the addition of one, two, or more non-opioid analgesic modes including, nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenase-2 inhibitors, paracetamol/acetaminophen, peripheral nerve blocks, steroids, gabapentin/pregabalin, or ketamine. Multilevel multivariable regression models measured associations between multimodal analgesia and opioid prescription (primary outcome; oral morphine equivalents). Secondary outcomes included opioid- and OSA-related complications, and resource utilisation. Odds ratios (OR) or % change and 95% confidence intervals (CI) are reported. RESULTS: Among 181 182 OSA patients included, 88.5% (n = 160 299) received multimodal analgesia with increasing utilisation trends. Multivariable models showed stepwise beneficial postoperative outcome effects with increasing additional analgesic modes compared with opioid-only analgesia. In patients who received more than two additional analgesia modes (n = 64 174), opioid dose prescription decreased by 14.9% (CI -17.0%; -12.7%), while odds were significantly decreased for gastrointestinal complications (OR 0.65, CI 0.53; 0.78), mechanical ventilation (OR 0.23, CI 0.16; 0.32), and critical care admission (OR 0.60, CI 0.48; 0.75), all P<0.0001. CONCLUSIONS: In a population at high risk for perioperative complications from OSA, multimodal analgesia was associated with a stepwise reduction in opioid use and complications, including critical respiratory failure.
Subject(s)
Analgesics, Non-Narcotic/administration & dosage , Arthroplasty, Replacement, Hip/adverse effects , Arthroplasty, Replacement, Knee/adverse effects , Pain Management/methods , Pain, Postoperative/prevention & control , Sleep Apnea, Obstructive/complications , Aged , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/adverse effects , Databases, Factual , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Therapy, Combination , Drug Utilization/statistics & numerical data , Elective Surgical Procedures/adverse effects , Female , Health Resources/statistics & numerical data , Humans , Male , Middle Aged , North Carolina/epidemiology , Pain, Postoperative/epidemiology , Pain, Postoperative/etiology , Postoperative Care/methods , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Postoperative Complications/prevention & control , Retrospective Studies , Sleep Apnea, Obstructive/epidemiologyABSTRACT
BACKGROUND: Neuraxial anaesthesia is frequently used for lower limb arthroplasty but it is unclear whether benefits vary among patients receiving different subtypes of neuraxial anaesthesia. We evaluated whether differences in risk for adverse postoperative outcomes exist between patients receiving combined spinal and epidural (CSE), epidural, or spinal anaesthesia. METHODS: In this retrospective cohort study, we identified 40 852 patients who underwent total hip and knee arthroplasty (THA and TKA) procedures under neuraxial anaesthesia (34 301 CSE, 2464 epidural, 4087 spinal) between 2005 and 2014 at a single institution. We used multivariable logistic regression to evaluate the following outcomes: cardiac, pulmonary, gastrointestinal, renal/genitourinary, and thromboembolic complications, and prolonged length of stay. RESULTS: Compared with CSE, spinal anaesthesia was associated with reduced adjusted odds for cardiac [odds ratio (OR), 0.68; 95% confidence interval (CI), 0.52-0.89], pulmonary (OR: 0.51; 95% CI: 0.38-0.68), gastrointestinal (OR: 0.50; 95% CI: 0.32-0.78), and thromboembolic complications (OR: 0.40; 95% CI: 0.23-0.73), and prolonged length of stay (OR: 0.72; 95% CI: 0.66-0.80). Patients who received epidural anaesthesia did not have significantly different odds for any outcomes compared with CSE patients. CONCLUSIONS: We identified clear differences in risk for certain postoperative events by subtype of neuraxial anaesthesia, suggesting that spinal anaesthesia is associated with the most favourable outcomes profile.
Subject(s)
Anesthesia, Conduction/methods , Anesthesia, Epidural/methods , Anesthesia, Spinal/methods , Arthroplasty, Replacement/methods , Aged , Arthroplasty, Replacement, Hip/methods , Arthroplasty, Replacement, Knee/methods , Cohort Studies , Female , Humans , Length of Stay , Male , Middle Aged , Postoperative Complications/epidemiology , Retrospective Studies , Treatment OutcomeABSTRACT
BACKGROUND: Postoperative delirium continues to pose major clinical difficulties. While unmodifiable factors (e.g. age and comorbidity burden) are commonly studied risk factors for delirium, the role of modifiable factors, such as anaesthesia type and commonly used perioperative medications, remains understudied. This study aims to evaluate the role of modifiable factors for delirium after hip and knee arthroplasties. METHODS: We performed a retrospective study of 41 766 patients who underwent hip or knee arthroplasties between 2005 and 2014 at a single institution. Data were collected as part of routine patient care. Multivariable logistic regression models assessed associations between anaesthesia type and commonly used perioperative medications (opioids, benzodiazepines, and ketamine) and postoperative delirium. Odds ratios (OR) and 95% confidence intervals (CI) are reported. Various sensitivity analyses are also considered, including multiple imputation methods to address missing data. RESULTS: Postoperative delirium occurred in 2.21% (n=922) of all patients. While patients who received neuraxial anaesthesia were at lower risk for postoperative delirium (compared with general anaesthesia; epidural OR 0.59 CI 0.38-0.93; spinal OR 0.55 CI 0.37-0.83; combined spinal/epidural OR 0.56 CI 0.40-0.80), those given intraoperative ketamine (OR 1.27 CI 1.01-1.59), opioids (OR 1.25 CI 1.09-1.44), postoperative benzodiazepines (OR 2.47 CI 2.04-2.97), and ketamine infusion (OR 10.59 CI 5.26-19.91) were at a higher risk. CONCLUSIONS: In this cohort of hip and knee arthroplasty patients, anaesthesia type and perioperative medications were associated with increased odds for postoperative delirium. Our results support the notion that modifiable risk factors may exacerbate or attenuate risk for postoperative delirium.
Subject(s)
Anesthesia/methods , Arthroplasty, Replacement, Hip , Arthroplasty, Replacement, Knee , Delirium/prevention & control , Postoperative Complications/prevention & control , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Retrospective Studies , Risk FactorsABSTRACT
This article describes the certification pathways for Physiatrists in the United States, reviews the licensure, certification and accreditation pathways for rehabilitation facilities in the United States, examines the evolving models of health care in the United States, evaluates the impact of health care reform within the United States with particular emphasis on the intrinsic value of Physiatric services, and discusses how the intersection of certification, accreditation and emerging models of care in the United States present opportunities for Physiatrists instead of threats. These principles and practices should be relevant to Physiatrists and physiatric programs globally.
Subject(s)
Certification/organization & administration , Physical and Rehabilitation Medicine/education , Delivery of Health Care/organization & administration , Education, Medical, Continuing , Health Care Reform , Humans , Licensure , United StatesABSTRACT
BACKGROUND: Cancer is the second leading cause of death among Americans. The World Health Organization has mandated an integrated approach to palliative care in the treatment of patients with cancer. However, medical decision making in the setting of life-threatening disease remains complicated. METHODS: An integrated palliative care approach depends on the skillful blend of antineoplastic, supportive, and palliative interventions. For standardizing care plans, documenting palliative interventions, and tracking and improving outcomes, palliative care elements are defined. At our institute, medical symptom management, psychosocial support, and advance care planning are incorporated into routine cancer care. RESULTS: Although progress is being made toward integrating palliative care in the field of oncology, further efforts are needed to ensure that cancer patients and their families who need palliative care receive it. CONCLUSIONS: If fully implemented, the integrated palliative care approach will result in quaternary prevention, ie, the prevention of suffering.
Subject(s)
Interprofessional Relations , Medical Oncology/organization & administration , Palliative Care/organization & administration , Patient Care Planning , Humans , Neoplasms/complications , Palliative Care/standards , Quality of Life , Terminal CareSubject(s)
Neoplasms/therapy , Palliative Care/methods , Quality of Life , Humans , Palliative Care/standards , Treatment OutcomeABSTRACT
Cancer patients experience pain in multiple sites and from several pathophysiologies of the symptom complex. The fluctuating nature of cancer pain intensity is a relevant clinical feature and depends on disease patterns and pain mechanisms. Breakthrough pain is defined as episodes of pain that "break through" the control of an otherwise effective analgesic therapy. Traditional ways of classifying pain in the cancer population include distinguishing pain associated with the treatments, the tumor, or unrelated to both and between chronic and acute pain. In focusing on the care of the cancer patient with pain, it is useful to be familiar with the characteristics of the typical syndrome found in association with different tumor types and anatomic locations. An understanding of the etiology of pain in relation to the cancer is useful in recognizing these complications and in treating them. This article reviews the methods presently applied to the classification of cancer pain and highlights the need for more research in this area.
Subject(s)
Neoplasms/complications , Pain/classification , Pain/etiology , Humans , Neoplasm Staging , Neoplasms/physiopathology , Pain/physiopathology , Pain Measurement , Severity of Illness IndexABSTRACT
One of the challenges that healthcare organizations face today is how to effectively establish, document, and evaluate competency in intravenous practice. The process used to define practice parameters based on national certification and credentialing versus organizational policies is described. Key attributes, the role of mentoring, and adverse outcomes are addressed.
Subject(s)
Certification/organization & administration , Clinical Competence/standards , Infusions, Intravenous/nursing , Specialties, Nursing/education , Specialties, Nursing/organization & administration , Education, Nursing, Continuing , Humans , Information Services , Inservice Training , Internet , Job Description , Mentors , Outcome Assessment, Health CareABSTRACT
T-cell-rich B-cell lymphoma (TCRBCL) is an uncommon and recently recognized variant of B-cell non-Hodgkin lymphoma characterized by a few large neoplastic B cells amid a predominant population of reactive T lymphocytes and variable numbers of histiocytes. Morphologically, TCRBCL resembles a variety of non-Hodgkin lymphomas and Hodgkin disease. Accurate diagnosis and proper treatment are essential to assure a favorable prognosis. To our knowledge, this is the first report of ethmoid sinus presentation of TCRBCL in an Epstein-Barr virus-negative 51-year-old man. Combined chemotherapy and radiotherapy were administered based on the correct diagnosis. The patient has had a complete response with no recurrence during the 5-year follow-up.
Subject(s)
Ethmoid Sinus/pathology , Lymphoma, B-Cell/pathology , Paranasal Sinus Neoplasms/pathology , T-Lymphocytes/pathology , Antigens, CD/biosynthesis , Biomarkers, Tumor/biosynthesis , Biopsy , Combined Modality Therapy , Ethmoid Sinus/diagnostic imaging , Follow-Up Studies , Humans , Lymphoma, B-Cell/diagnostic imaging , Lymphoma, B-Cell/therapy , Magnetic Resonance Imaging , Male , Middle Aged , Paranasal Sinus Neoplasms/diagnostic imaging , Paranasal Sinus Neoplasms/therapy , Tomography, X-Ray ComputedABSTRACT
BACKGROUND: Barriers to pain management include physicians' lack of knowledge and attitudes. Our aim was to investigate future physicians' knowledge and attitudes toward pain and the use of opioid analgesics. METHODS: We tested a medical school class during their freshman and senior years. Stepwise regression analysis was used to identify the personal traits that predicted opiophobia. RESULTS: The professionalization process of medical training may reinforce negative attitudes. Psychologic characteristics were associated with reluctance to prescribe opioids, and fears of patient addiction and drug regulatory agency sanctions. CONCLUSIONS: Consistent attitudes were found in senior medical students with preferences for certain specialty areas and the practitioners of their future specialties, suggesting a "preselection" effect. Higher scores on reliance on high technology, external locus of control, and intolerance of clinical uncertainty were associated with higher scores on one or more of the three dimensions of opiophobia. Implications for medical education are discussed.
Subject(s)
Analgesics, Opioid/therapeutic use , Attitude to Health , Curriculum , Education, Medical , Pain/drug therapy , Students, Medical , Acute Disease , Attitude of Health Personnel , Chronic Disease , Clinical Competence , Drug Utilization , Drug and Narcotic Control/legislation & jurisprudence , Follow-Up Studies , Humans , Internal-External Control , Medical Laboratory Science , Opioid-Related Disorders , Personality , Prejudice , Regression Analysis , Specialization , Students, Medical/psychologyABSTRACT
BACKGROUND: Despite extensive progress in the scientific understanding of pain in humans, serious mismanagement and undermedication in treating acute and chronic pain is a continuing problem. This study was designed to examine the barriers to adequate pain management, especially as they might be associated with community size and medical discipline. METHODS: A 59-item survey was used to measure physicians' attitudes, knowledge, and psychologic factors that contribute to pain management practices. RESULTS: Overall, a significant number of physicians in this survey revealed opiophobia (prejudice against the use of opioid analgesics), displayed lack of knowledge about pain and its treatment, and had negative views about patients with chronic pain. There were significant differences among groups of physicians based on size of geographic practice area and medical discipline. CONCLUSIONS: New educational strategies are needed to overcome these barriers and to improve pain treatment in routine medical practice. The effect of practice milieu must be taken into consideration.
Subject(s)
Analgesics, Opioid/therapeutic use , Attitude of Health Personnel , Pain/drug therapy , Physicians , Acute Disease , Age Factors , Chronic Disease , Clinical Competence , Drug Utilization , Drug and Narcotic Control/legislation & jurisprudence , Education, Medical , Female , Humans , Male , Neoplasms/physiopathology , Opioid-Related Disorders , Pain/physiopathology , Physician-Patient Relations , Physicians/psychology , Population Density , Prejudice , Professional Practice Location , Sex Factors , Specialization , TexasABSTRACT
The overall approach to pain management encompassed in these guidelines is comprehensive. It is based on objective pain assessments, utilizes both pharmacologic and nonpharmacologic interventions, and requires continual reevaluation of the patient. The NCCN Cancer Pain Practice Guidelines Panel believes that cancer pain can be well controlled in the vast majority of patients if the algorithms presented are systematically applied, carefully monitored, and tailored to the needs of the individual patient.
Subject(s)
Neoplasms/complications , Pain/drug therapy , Acetaminophen/therapeutic use , Analgesics, Non-Narcotic/therapeutic use , Analgesics, Opioid/therapeutic use , Humans , Pain/etiology , Pain/psychology , Pain Measurement/methods , United StatesABSTRACT
Among 644 senior medical students a 14-item scale which was internally consistent indicated no change over the 6 years of testing in intent to reserve opioids for terminally ill.
Subject(s)
Attitude to Health , Drug Prescriptions , Narcotics/therapeutic use , Neoplasms/complications , Pain/drug therapy , Pain/etiology , Students, Medical/psychology , Surveys and Questionnaires , Humans , Statistics as TopicABSTRACT
OBJECTIVES: (1) To assess the feasibility and tolerability of the therapeutic transdermal fentanyl system (TTS-fentanyl) by using a clinical protocol developed for children with cancer pain. (2) To estimate the pediatric pharmacokinetic parameters of TTS-fentanyl. METHODS: The drug was administered in open-label fashion; and measures of analgesia, side effects, and skin changes were obtained for a minimum of 2 doses (6 treatment days). Blood specimens were analyzed for plasma fentanyl concentrations. The pharmacokinetics of TTS-fentanyl were estimated by using a mixed effect modeling approach. RESULTS: Treatment was well tolerated. Ten of the 11 patients who completed the 2 doses continued treatment with TTS-fentanyl. The duration of treatment ranged from 6 to 275 days. The time to reach peak plasma concentration ranged from 18 hours to >66 hours in patients receiving the 25 microg/h patch. Compared with published pharmacokinetic data from adults, the mean clearance and volume of distribution of transdermal fentanyl were the same, but the variability was less. CONCLUSIONS: Treatment of children with TTS-fentanyl is feasible and well tolerated and yields fentanyl pharmacokinetic parameter estimates similar to those for adults. A larger study is required to confirm these findings and further test the clinical protocol.
Subject(s)
Analgesics, Opioid/administration & dosage , Fentanyl/administration & dosage , Neoplasms/complications , Pain, Intractable/drug therapy , Administration, Cutaneous , Adolescent , Analgesics, Opioid/adverse effects , Analgesics, Opioid/blood , Analgesics, Opioid/pharmacokinetics , Child , Feasibility Studies , Fentanyl/adverse effects , Fentanyl/blood , Fentanyl/pharmacokinetics , Humans , Neoplasms/blood , Pain Measurement , Pain, Intractable/blood , Pain, Intractable/etiology , Treatment OutcomeABSTRACT
Postamputation phenomena, including painful and nonpainful phantom sensations occur following loss of limbs and other body parts. Peripheral and central nervous system mechanisms play a role in persistent phantom pain. Understanding the pathophysiology of this syndrome has improved in recent years. Comprehensive evaluation and a multimodality treatment approach comprise the current standard of care of the patient with phantom pain.
Subject(s)
Phantom Limb/diagnosis , Central Nervous System/physiopathology , Combined Modality Therapy , Humans , Nociceptors/physiopathology , Pain Measurement , Peripheral Nerves/physiopathology , Phantom Limb/physiopathology , Phantom Limb/therapySubject(s)
Analgesics/therapeutic use , Neoplasms/complications , Pain, Intractable/drug therapy , Anti-Inflammatory Agents/therapeutic use , Humans , Narcotics/administration & dosage , Narcotics/therapeutic use , Neoplasms/drug therapy , Nervous System Physiological Phenomena , Nociceptors/physiology , Pain/etiology , Pain, Intractable/physiopathology , Second Messenger Systems/physiologyABSTRACT
Stingers are the most common athletically induced nerve injury of the cervical spine, but often underdiagnosed or inadequately assessed. In addition to neurologic dysfunction, biomechanical and postural faults are frequently associated with stingers. This article addresses the pathomechanics of the stinger, comprehensive clinical assessment, appropriate diagnostic testing, and a thorough review of rehabilitation techniques to allow return to competition. The principles and practical suggestions can be applied to most cervical spine injuries.
Subject(s)
Athletic Injuries/rehabilitation , Cervical Vertebrae/injuries , Spinal Injuries/rehabilitation , Sports , Athletic Injuries/physiopathology , Biomechanical Phenomena , Cervical Vertebrae/physiopathology , Humans , Spinal Injuries/physiopathology , Treatment OutcomeABSTRACT
Controlled-release oral formulations of oxycodone and morphine are both suitable analgesics for moderate to severe pain. They were compared in cancer-pain patients randomized to double-blind treatment with controlled-release oxycodone (n = 48) or controlled-release morphine (n = 52) every 12 h for up to 12 days. Stable analgesia was achieved by 83% of controlled-release oxycodone and 81% of controlled-release morphine patients in 2 days (median). Following titration to stable analgesia, pain intensity (0=none to 3=severe) decreased from baseline within each group (p = 0.005), from 1.9 (0.1) to 1.3 (0.1), mean (SE), with controlled-release oxycodone, and from 1.6 (0.1) to 1.0 (0.1) with controlled-release morphine (no significant between-group differences). Typical opioid adverse experiences were reported in both groups. Hallucinations were reported only with controlled-release morphine (n = 2). Visual analog scores (VAS) for 'itchy' and 'scratchin' were lower with controlled-release oxycodone (p = 0.044), as was peak-to-trough fluctuation in steady-state plasma concentration (p = 0.004). The correlation between plasma concentration and dose was stronger (p = 0.026) for oxycodone (0.7) than morphine (0.3). The relationship between pain intensity (VAS) and plasma concentration was more positive for oxycodone (p = 0.046). There was a positive relationship between morphine-6-glucuronide concentrations and urea nitrogen and creatinine levels (p = 0.001). Controlled-release oxycodone was as effective as controlled-release morphine in relieving chronic cancer-related pain, and as easily titrated to the individual's need for pain control. While adverse experiences were similar, controlled-release oxycodone was associated with less itching and no hallucinations. Controlled-release oxycodone provides a rational alternative to controlled-release morphine for the management of moderate to severe cancer-related pain.